Zobrazeno 1 - 10
of 272
pro vyhledávání: '"Hideyuki, Mishima"'
Autor:
Mirai Ido, Kimihito Fujii, Hideyuki Mishima, Akihito Kubo, Masayuki Saito, Hirona Banno, Yukie Ito, Manami Goto, Takahito Ando, Yukako Mouri, Junko Kousaka, Tsuneo Imai, Shogo Nakano
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Aim The aim of this study was to investigate genetic alterations within breast cancer in the setting of recurrent or de novo stage IV disease. Patients and methods : This study included 22 patients with recurrent breast cancer (n = 19) and i
Externí odkaz:
https://doaj.org/article/34d366c9102448fa859ba2a262a2204e
Autor:
Takashi Kojima, Hiroaki Ikeda, Sachiko Okamoto, Junichi Mineno, Hiroshi Shiku, Shigehisa Kitano, Shinichi Kageyama, Yoshihiro Miyahara, Mikiya Ishihara, Daisuke Tomura, Ikuei Nukaya, Tetsuro Sasada, Noboru Yamamoto, Takashi Watanabe, Hideyuki Mishima, Alessandra Nardin, Evan Newell, Hidefumi Kato, Hiroyoshi Hattori, Takeru Funakoshi, Eiichi Sato, Hideto Chono, Muhammad Faris Kairi, Phuong Diem Hoang Nguyen, Yannick Simoni, Michael Fehlings
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/abdfa23a1dce47a7a164f412340c65ed
Autor:
Hiroyuki Hakoda, Yasuharu Sekine, Hideo Ichimura, Kazumitsu Ueda, Shigeo Aoki, Hideyuki Mishima, Akihiro Sako, Keisuke Kobayashi, Akiko Sakata, Yukio Sato
Publikováno v:
Surgical Case Reports, Vol 5, Iss 1, Pp 1-5 (2019)
Abstract Background Patients with liver metastasis from non-small lung cancer (NSCLC) usually have multiple metastases at other sites and thus rarely undergo liver surgery. We present a case involving successful resection of rapidly growing liver met
Externí odkaz:
https://doaj.org/article/6a7af095c18a4a458b2ec7165be0ae38
Publikováno v:
Journal of Minimal Access Surgery, Vol 14, Iss 4, Pp 277-284 (2018)
Background: Although the number of reports on laparoscopic hepatic resection (LHR) has increased, studies of long-term outcomes regarding tumor recurrence and patient survival compared to the conventional open approach are limited. We evaluated the l
Externí odkaz:
https://doaj.org/article/c37d06507e814bd3909194926f546ccc
Autor:
Jun Watanabe, Hiromichi Maeda, Takeshi Nagasaka, Mitsuru Yokota, Keiji Hirata, Naoya Akazawa, Yoshinori Kagawa, Takeshi Yamada, Manabu Shiozawa, Takayuki Ando, Takeshi Kato, Hideyuki Mishima, Junichi Sakamoto, Koji Oba, Naoki Nagata
Publikováno v:
International Journal of Cancer. 151:2172-2181
Autor:
Mirai Ido, Kimihito Fujii, Hideyuki Mishima, Akihito Kubo, Masayuki Saito, Hirona Banno, Yukie Ito, Manami Goto, Takahito Ando, Yukako Mouri, Junko Kousaka, Tsuneo Imai, Shogo Nakano
Aim: The aim of this study was to investigate genetic alterations within breast cancer in the setting of recurrent or de novo stage IV disease. Patients and Methods: This study included 22 patients with recurrent breast cancer (n=19) and inoperable d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb1f2ac368b2de0a2416ef6e120717e1
https://doi.org/10.21203/rs.3.rs-2785270/v1
https://doi.org/10.21203/rs.3.rs-2785270/v1
Autor:
Takehito MARUYAMA, Rina MATSUMOTO, Keiichi ARAKAWA, Shigeo AOKI, Hideyuki MISHIMA, Akihiro SAKO
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 83:2024-2029
Publikováno v:
Choonpa Igaku. 49:151-157
Autor:
Takumi Habu, Akihiro Sako, Kotaro Nishida, Koichi Komatsu, Keiichi Arakawa, Takehito Maruyama, Shigeo Aoki, Hideyuki Mishima, Yuichi Matsui
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 54:869-875
Autor:
Mikiya Ishihara, Shigehisa Kitano, Shinichi Kageyama, Yoshihiro Miyahara, Noboru Yamamoto, Hidefumi Kato, Hideyuki Mishima, Hiroyoshi Hattori, Takeru Funakoshi, Takashi Kojima, Tetsuro Sasada, Eiichi Sato, Sachiko Okamoto, Daisuke Tomura, Ikuei Nukaya, Hideto Chono, Junichi Mineno, Muhammad Faris Kairi, Phuong Diem Hoang Nguyen, Yannick Simoni, Alessandra Nardin, Evan Newell, Michael Fehlings, Hiroaki Ikeda, Takashi Watanabe, Hiroshi Shiku
Publikováno v:
Journal for immunotherapy of cancer. 10(6)
BackgroundBecause of the shortage of ideal cell surface antigens, the development of T-cell receptor (TCR)-engineered T cells (TCR-T) that target intracellular antigens such as NY-ESO-1 is a promising approach for treating patients with solid tumors.